Clinical Trial Update: Efficacy and Mechanisms of GLN Dipeptide in the SICU [Phase 3]

View source ↗

Summary

Phase 3 trial update on GLN dipeptide in critically ill patients, reporting efficacy and mechanism findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• GLN dipeptide (glutamine dipeptide)

Snippet

Sponsor: Emory University | Conditions: Critical Illness | Phase 3 | Status: COMPLETED | Results posted: 2014-02-13